Home Cart 0 Sign in  
X

[ CAS No. 2789-25-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2789-25-5
Chemical Structure| 2789-25-5
Chemical Structure| 2789-25-5
Structure of 2789-25-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2789-25-5 ]

Related Doc. of [ 2789-25-5 ]

Alternatived Products of [ 2789-25-5 ]

Product Details of [ 2789-25-5 ]

CAS No. :2789-25-5 MDL No. :MFCD07368898
Formula : C5H4ClN3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :PDQAWJXOYURKPI-UHFFFAOYSA-N
M.W : 173.56 Pubchem ID :10965014
Synonyms :

Calculated chemistry of [ 2789-25-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.47
TPSA : 84.73 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.89
Log Po/w (XLOGP3) : 1.51
Log Po/w (WLOGP) : 1.23
Log Po/w (MLOGP) : -0.7
Log Po/w (SILICOS-IT) : -0.77
Consensus Log Po/w : 0.43

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.2
Solubility : 1.08 mg/ml ; 0.00624 mol/l
Class : Soluble
Log S (Ali) : -2.9
Solubility : 0.22 mg/ml ; 0.00127 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.66
Solubility : 3.81 mg/ml ; 0.0219 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.05

Safety of [ 2789-25-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2789-25-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2789-25-5 ]
  • Downstream synthetic route of [ 2789-25-5 ]

[ 2789-25-5 ] Synthesis Path-Upstream   1~22

  • 1
  • [ 2789-25-5 ]
  • [ 2770-01-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 2
  • [ 2789-25-5 ]
  • [ 3243-24-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 3
  • [ 14432-13-4 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: at 20 - 100℃; for 1 h;
Stage #2: With ammonia In water at 20℃;
2-ChloiO-4-nitroaminopyridine (10.0 g, mol) was carefully dissolved in 100 mL of concentrated sulfuric acid at room temperature and heated 100 0C for Ih. After the solution was cooled to room temperature, it was poured onto 250 g of crushed ice and treated with concentrated ammonium hydroxide until pH was reached at 3 while the temperature was kept below 200C with ice bath. The yellow solid was separated and extracted with ethyl acetate (200 ml x 3) from aqueous layer. The collected organic layer was concentrated and the residue was purified with silica gel column chromatography (hexane: EtOAc = 4: 1 to EtOAc v/v) to give 6.0 g of 4-Amino-2-chloro-3-nitropyridine in 70 percent yield and 2.0 g of 4-amino-2- Chloro-5-nitropyridine in 25 percent yield. 4-Amino-2-chloro-3-nitropyridine: mp 179-181 °C; UV (H2O) λmax 238.0 (ε 13586, pH 11), 1H-NMR (DMSO, 500 MHz) δ 7.91 (d, J= 6.0, IH), 7.37 (s, 2H), 6.83 (d, J = 6.0, IH); 13C-NMR (DMSO, 125 MHz) δ 149.54, 149.24, 142.69, 142.33, 122.45; 4-amino-2-chloro-5-nitropyridine: 1H-NMR (DMSO, 500 MHz) δ 8.85 (s, IH), 7.37 (s, 2H), 6.96 (s, IH).
Reference: [1] Patent: WO2007/47793, 2007, A2, . Location in patent: Page/Page column 87
[2] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[3] Chem.Abstr., 1957, p. 12089
[4] Nucleosides, nucleotides and nucleic acids, 2004, vol. 23, # 1-2, p. 67 - 76
[5] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
  • 4
  • [ 14432-12-3 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Patent: WO2006/84281, 2006, A1, . Location in patent: Page/Page column 187
[2] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
[3] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
[4] Patent: CN103819398, 2016, B, . Location in patent: Paragraph 0030-0038
[5] European Journal of Medicinal Chemistry, 2018, vol. 156, p. 240 - 251
  • 5
  • [ 109-09-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 6
  • [ 2402-95-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 7
  • [ 14432-16-7 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 8
  • [ 14432-13-4 ]
  • [ 7664-93-9 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[2] Chem.Abstr., 1957, p. 12089
  • 9
  • [ 14432-13-4 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: at 20 - 100℃; for 1 h;
Stage #2: With ammonia In water at 20℃;
2-ChloiO-4-nitroaminopyridine (10.0 g, mol) was carefully dissolved in 100 mL of concentrated sulfuric acid at room temperature and heated 100 0C for Ih. After the solution was cooled to room temperature, it was poured onto 250 g of crushed ice and treated with concentrated ammonium hydroxide until pH was reached at 3 while the temperature was kept below 200C with ice bath. The yellow solid was separated and extracted with ethyl acetate (200 ml x 3) from aqueous layer. The collected organic layer was concentrated and the residue was purified with silica gel column chromatography (hexane: EtOAc = 4: 1 to EtOAc v/v) to give 6.0 g of 4-Amino-2-chloro-3-nitropyridine in 70 percent yield and 2.0 g of 4-amino-2- Chloro-5-nitropyridine in 25 percent yield. 4-Amino-2-chloro-3-nitropyridine: mp 179-181 °C; UV (H2O) λmax 238.0 (ε 13586, pH 11), 1H-NMR (DMSO, 500 MHz) δ 7.91 (d, J= 6.0, IH), 7.37 (s, 2H), 6.83 (d, J = 6.0, IH); 13C-NMR (DMSO, 125 MHz) δ 149.54, 149.24, 142.69, 142.33, 122.45; 4-amino-2-chloro-5-nitropyridine: 1H-NMR (DMSO, 500 MHz) δ 8.85 (s, IH), 7.37 (s, 2H), 6.96 (s, IH).
Reference: [1] Patent: WO2007/47793, 2007, A2, . Location in patent: Page/Page column 87
[2] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[3] Chem.Abstr., 1957, p. 12089
[4] Nucleosides, nucleotides and nucleic acids, 2004, vol. 23, # 1-2, p. 67 - 76
[5] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
  • 10
  • [ 5975-12-2 ]
  • [ 2789-25-5 ]
YieldReaction ConditionsOperation in experiment
71% With ammonia In ethanol at 20℃; for 96 h; 3b)
4-amino-2-chloro-3-nitropyridine
A solution of 28.0 g (0.193 mol) of 2,4-dichloro-3-nitropyridine in 300 ml of ammonia-saturated ethanol was stirred for four days at ambient temperature, then evaporated to dryness and the crude product thus obtained was purified by column chromatography (silica gel, eluant:dichloromethane with 0-5percent ethanol).
Yield: 71percent of theory. C5H4ClN3O2 (173.56) Mass spectrum: (M+H)+=174/6
40% With ammonia In ethanol at 20℃; for 7 h; [1208] A solution of L-1 (20.00 g, 103.64 mmol, 1.00 eq) in ethanolic NH3 (600 ml of absolute ethanol saturated at 5°C with dry NH3) was stirred at rt for 7h. Then, the reaction solution was concentrated in vacuum to get a residue. The residue was triturated with boiling chloroform (120 ml). The resulting insoluble solid was filtered and dried in vacuum. Crystallization of this material from EA (200 ml) gave L-2 (7.20 g, 41.62 mmol, 40percent yield) as a brown solid.
Reference: [1] Patent: US2005/20574, 2005, A1, . Location in patent: Page/Page column 16
[2] Patent: WO2015/153683, 2015, A1, . Location in patent: Paragraph 1208
  • 11
  • [ 14432-12-3 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Patent: WO2006/84281, 2006, A1, . Location in patent: Page/Page column 187
[2] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
[3] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
[4] Patent: CN103819398, 2016, B, . Location in patent: Paragraph 0030-0038
[5] European Journal of Medicinal Chemistry, 2018, vol. 156, p. 240 - 251
  • 12
  • [ 14432-12-3 ]
  • [ 2789-25-5 ]
YieldReaction ConditionsOperation in experiment
44% at 0℃; for 1 h; Potassium nitrate (7.86 g, 0.0784 mol) was added portionwise to 2-chloro-4-aminopyridine (10.00 g, 0.078 mol) in concentrated sulfuric acid (80 mL) at 0 ° C, and the reaction was continued at 0 ° C for 1 hour. After completion, the reaction solution was poured into crushed ice, concentrated aqueous ammonia was added to adjust the pH to 3, stirred for 15 minutes, filtered, and a solid was collected. Add solid to concentrated sulfuric acid (80mL), heat to 80 ° C for 5 hours, cool, pour the reaction solution into crushed ice, add concentrated ammonia to adjust the pH to 3, stir for 15 minutes, filter, collect solids, through silica gel column Chromatographic purification,Elution with ethyl acetate/petroleum gradient (10-20percent) gave product ( 6.00 g, 44percent).
Reference: [1] Patent: CN108498504, 2018, A, . Location in patent: Paragraph 0022; 0023; 0024; 0025
[2] Nucleosides, nucleotides and nucleic acids, 2004, vol. 23, # 1-2, p. 67 - 76
[3] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[4] Chem.Abstr., 1957, p. 12089
  • 13
  • [ 5470-18-8 ]
  • [ 2789-25-5 ]
Reference: [1] Chemical Communications, 1998, # 15, p. 1519 - 1520
[2] Journal of the American Chemical Society, 2017, vol. 139, # 33, p. 11622 - 11628
  • 14
  • [ 5470-18-8 ]
  • [ 2789-25-5 ]
  • [ 84487-03-6 ]
Reference: [1] Liebigs Annalen der Chemie, 1991, # 9, p. 875 - 878
[2] Chemical Communications, 1998, # 15, p. 1519 - 1520
  • 15
  • [ 89282-12-2 ]
  • [ 2789-25-5 ]
Reference: [1] Patent: WO2015/153683, 2015, A1,
  • 16
  • [ 109-09-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 17
  • [ 2402-95-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 18
  • [ 14432-16-7 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 19
  • [ 14432-13-4 ]
  • [ 7664-93-9 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[2] Chem.Abstr., 1957, p. 12089
  • 20
  • [ 2789-25-5 ]
  • [ 24501-21-1 ]
Reference: [1] Roczniki Chemii, 1956, vol. 30, p. 1139,1145[2] Chem.Abstr., <1957> 12089,
  • 21
  • [ 2789-25-5 ]
  • [ 88511-57-3 ]
YieldReaction ConditionsOperation in experiment
69% With water In dimethyl sulfoxide at 130℃; for 4 h; 3c)
4-amino-2-hydroxy-3-nitropyridine
A solution of 18.0 g (104 mmol) of 4-amino-2-chloro-3-nitropyridine in 120 ml dimethylsulphoxide and 30 ml of water was stirred for four hours at 130° C.
The solution was then cooled and left to stand overnight while cooling with ice.
The product that crystallized out was suction filtered, washed with a little water and dried at 50° C.
Yield: 69percent of theory. C5H5N3O3 (155.11) Mass spectrum: (M+H)+=156 (M-H)-=154
Reference: [1] Patent: US2005/20574, 2005, A1, . Location in patent: Page/Page column 16
  • 22
  • [ 5470-18-8 ]
  • [ 2789-25-5 ]
  • [ 84487-03-6 ]
Reference: [1] Liebigs Annalen der Chemie, 1991, # 9, p. 875 - 878
[2] Chemical Communications, 1998, # 15, p. 1519 - 1520
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2789-25-5 ]

Chlorides

Chemical Structure| 5470-18-8

[ 5470-18-8 ]

2-Chloro-3-nitropyridine

Similarity: 0.89

Chemical Structure| 2897-43-0

[ 2897-43-0 ]

2,6-Dichloro-3-nitropyridin-4-amine

Similarity: 0.85

Chemical Structure| 405230-90-2

[ 405230-90-2 ]

2-Chloro-5-fluoro-3-nitropyridin-4-amine

Similarity: 0.84

Chemical Structure| 23056-39-5

[ 23056-39-5 ]

2-Chloro-4-methyl-3-nitropyridine

Similarity: 0.84

Chemical Structure| 21427-62-3

[ 21427-62-3 ]

2,5-Dichloro-3-nitropyridine

Similarity: 0.84

Amines

Chemical Structure| 2897-43-0

[ 2897-43-0 ]

2,6-Dichloro-3-nitropyridin-4-amine

Similarity: 0.85

Chemical Structure| 405230-90-2

[ 405230-90-2 ]

2-Chloro-5-fluoro-3-nitropyridin-4-amine

Similarity: 0.84

Chemical Structure| 1681-37-4

[ 1681-37-4 ]

4-Amino-3-nitropyridine

Similarity: 0.77

Chemical Structure| 2604-39-9

[ 2604-39-9 ]

2-Chloro-5-nitropyridin-4-amine

Similarity: 0.76

Chemical Structure| 39217-08-8

[ 39217-08-8 ]

2-Chloropyridine-3,4-diamine

Similarity: 0.75

Nitroes

Chemical Structure| 2578-45-2

[ 2578-45-2 ]

2-Chloro-3,5-dinitropyridine

Similarity: 0.91

Chemical Structure| 5470-18-8

[ 5470-18-8 ]

2-Chloro-3-nitropyridine

Similarity: 0.89

Chemical Structure| 2897-43-0

[ 2897-43-0 ]

2,6-Dichloro-3-nitropyridin-4-amine

Similarity: 0.85

Chemical Structure| 405230-90-2

[ 405230-90-2 ]

2-Chloro-5-fluoro-3-nitropyridin-4-amine

Similarity: 0.84

Chemical Structure| 21427-62-3

[ 21427-62-3 ]

2,5-Dichloro-3-nitropyridine

Similarity: 0.84

Related Parent Nucleus of
[ 2789-25-5 ]

Pyridines

Chemical Structure| 2578-45-2

[ 2578-45-2 ]

2-Chloro-3,5-dinitropyridine

Similarity: 0.91

Chemical Structure| 5470-18-8

[ 5470-18-8 ]

2-Chloro-3-nitropyridine

Similarity: 0.89

Chemical Structure| 2897-43-0

[ 2897-43-0 ]

2,6-Dichloro-3-nitropyridin-4-amine

Similarity: 0.85

Chemical Structure| 405230-90-2

[ 405230-90-2 ]

2-Chloro-5-fluoro-3-nitropyridin-4-amine

Similarity: 0.84

Chemical Structure| 21427-62-3

[ 21427-62-3 ]

2,5-Dichloro-3-nitropyridine

Similarity: 0.84